This article was machine-drafted from the sources cited in its footnotes. It is not the official text of any law or court decision, and it is not legal advice (how articles are written).
Peraturan Badan Pengawas Obat dan Makanan 16/2026Regulation
Full titlePeraturan Badan Pengawas Obat dan Makanan Nomor 16 Tahun 2026 tentang Sertifikasi Cara Pembuatan Obat yang Baik dan Cara Distribusi Obat yang Baik
CitationPeraturan BPOM 16/2026
JurisdictionIndonesia
Enacted byHead of the Food and Drug Supervisory Agency (BPOM)
Signed3 September 2026
Promulgated29 September 2026
Effective29 September 2026
ReplacesPeraturan Kepala BPOM HK.04.1.33.12.11.09937 Tahun 2011 and Peraturan Kepala BPOM 25/2017

Peraturan Badan Pengawas Obat dan Makanan 16/2026 (Peraturan Badan Pengawas Obat dan Makanan Nomor 16 Tahun 2026 tentang Sertifikasi Cara Pembuatan Obat yang Baik dan Cara Distribusi Obat yang Baik) is an Indonesian agency regulation of the Food and Drug Supervisory Agency (Badan Pengawas Obat dan Makanan, BPOM) that sets the procedure by which BPOM certifies good manufacturing practice for medicines (Cara Pembuatan Obat yang Baik, CPOB) and good distribution practice for medicines (Cara Distribusi Obat yang Baik, CDOB). It was signed by the Head of BPOM, Taruna Ikrar, on 3 September 2026 and took effect on its promulgation on 29 September 2026.[1][2] It forms part of health sector regulation in Indonesia.

The regulation has 99 articles in seven chapters. The second chapter governs CPOB certificates for pharmaceutical manufacturers and other producers of medicines and drug materials, and the third governs CDOB certificates for pharmaceutical wholesalers, government pharmaceutical management facilities and the operators of electronic systems used to distribute medicines. Both certificates are valid for at most five years and both are applied for electronically.[3][4][5][6]

The remaining chapters provide for force majeure, administrative sanctions, transition and revocation. The regulation replaced BPOM's certification rules of 2011 for manufacturing and of 2017 for distribution, and partly revoked Peraturan BPOM 20/2025 on the CDOB standard. It keeps existing certificates valid until they expire, and gives national and provincial pharmaceutical management facilities five years, and district and city facilities seven years, from promulgation to obtain a CDOB certificate.[7][8]

Background

The preamble gives three reasons for the regulation: to ensure the safety, efficacy and quality of medicines and to give legal certainty in their manufacture and distribution through certification procedures suited to developments in science, technology and legal needs; to protect the public from medicines and drug materials that do not meet standards; and, because of developments in risk-based business licensing in the drug and food subsector, to replace the two certification rules issued by the Head of BPOM in 2011 and 2017.[9] Its legal bases include Peraturan Pemerintah 28/2024, the implementing regulation of the 2023 health law, and PP 28/2025 on risk-based business licensing, together with the presidential regulation on BPOM and BPOM's own rules on its organisation.[9:1]

Pasal 1 defines CPOB as the way of making medicines and drug materials that ensures their quality meets requirements and intended use, and CDOB as the way of distributing them that ensures quality along the distribution chain. A CPOB certificate is the document proving that a pharmaceutical industry or facility meets the CPOB standard; a CDOB certificate proves that the procurement, storage and distribution of medicines, including the electronic systems used to distribute them, apply the CDOB standard.[10]

Manufacturing certification

Pasal 2 requires pharmaceutical industries, institutions and facilities that make medicines or drug materials, including medicines made for clinical trials, to apply the CPOB standard, and allows institutions and facilities to be government bodies. Compliance is proved by a CPOB certificate issued by the Head of BPOM; for clinical-trial medicines a facility-use approval issued by BPOM may also serve as proof.[3:1] A certificate is granted for each building unit, according to the dosage form and the manufacturing process carried out at all or some of its stages. One process for one dosage form spread over several buildings receives a single certificate, while drug materials are certified per production line, biological products per line of the manufacturing process, and radiopharmaceuticals by route of administration or manufacture and by radionuclide.[3:2]

Applications are filed electronically through the online single submission system, integrated with BPOM's CPOB certification website; applicants outside the business-actor criteria of the government regulation on risk-based licensing apply through the BPOM website directly.[11] A registered applicant may apply for new certification, for changes to or extension of a certificate, and for approval, change or extension of a warehouse outside the factory site.[11:1] For a new certificate, BPOM verifies the documents within 10 working days, the applicant pays a non-tax state revenue fee within seven calendar days of the payment order, and BPOM then has 35 working days for evaluation and inspection, with the clock stopped while the applicant prepares its corrective and preventive actions (CAPA). A first-stage CAPA is due within 20 working days of the inspection results, and a second stage may follow within 60 working days.[12]

BPOM then approves or rejects the application. Rejection follows where the second-stage CAPA still fails the standard or is not submitted in time, where documents do not meet the requirements, or where inspection finds a critical non-conformity. A rejected applicant may not manufacture, forfeits its fee, and may reapply after at least six months, or after at least twelve months where it submitted untrue documents or invalid data.[13]

A CPOB certificate is valid for at most five years while the holder remains in operation and meets the standard. An extension must be sought no earlier than six months and no later than four months before it expires.[5:1][14] Adding a warehouse outside the factory site requires the approval of the Head of BPOM, which is likewise valid for at most five years.[15][5:2] A manufacturer that stops operating must return its certificate, and BPOM may then revoke the marketing authorisations of the medicines made at the facility and order their withdrawal or destruction.[16] Certificate holders must also comply with the terms of the certificate, report their business activities, apply for a change of certificate when production facilities change, and report the site master file of the pharmaceutical industry.[17]

Distribution certification

Pasal 62 requires business actors and pharmaceutical management facilities (Fasilitas Pengelolaan Kefarmasian) that procure, store and distribute medicines or drug materials, or that provide and operate electronic systems for distributing medicines, to apply the CDOB standard, proved by a CDOB certificate. The business actors are pharmaceutical wholesalers (Pedagang Besar Farmasi, PBF) and their branches, wholesalers of drug materials and their branches, and electronic system operators and electronic commerce operators. Pharmaceutical management facilities are those of central government, including the armed forces and the police, of regional governments and of state- and region-owned enterprises.[10:1][4:1]

The certificate must be held before operations begin, and a wholesaler that also runs an electronic distribution system must meet the requirements for electronic system operators as well.[4:2] Certificates are granted by product category, among them drug materials, cold-chain products, narcotics, psychotropics, prescription medicines, pharmaceutical precursors and medicines prone to misuse, and by activity.[4:3] A wholesaler must apply within six months of the issue of its licence and hold the certificate within twelve months.[18]

Applications go through BPOM's CDOB certification website, where registration is verified within five working days.[19] For a new certificate BPOM verifies the documents within five working days and inspects after payment. The applicant has 40 working days for each stage of CAPA, and inspection, evaluation of the CAPA and the decision must be completed within 49 working days of payment, with the clock stopped while the applicant prepares its CAPA.[20] A CDOB certificate is valid for at most five years, and its holder must seek extension between twelve and six months before it expires.[6:1][21] A wholesaler that ceases business must return the certificate; a branch returns its stock to its head office, and a head wholesaler returns stock to its supplier or destroys it.[22]

Force majeure and sanctions

Pasal 94 allows applications and certification to proceed manually, or to be postponed, in a force majeure event such as the failure of the electronic system, riots, fire or natural disaster. A postponement may last three months, and an application still incomplete after it is rejected; time limits stop running during the event.[23]

Pasal 95 subjects business actors that breach listed obligations, among them the warehouse approval requirement, the return of certificates, the holders' obligations under Pasal 61 and the requirement to hold a CDOB certificate before operating, to administrative sanctions imposed by the Head of BPOM: warning, strong warning, temporary suspension of activities, temporary closure of access to business licensing applications, freezing of the certificate, and revocation of the certificate. Pasal 96 refers the procedure to BPOM's regulation on follow-up to the results of supervision of medicines, drug materials, narcotics, psychotropics, precursors and addictive substances.[24]

Transition and revocation

Applications filed before the regulation took effect continue under the 2011 and 2017 rules, and existing CPOB and CDOB certificates remain valid until they expire. Holders of CPOB certificates must align their dosage forms and processes with the classification set by the Head of BPOM when they apply for extension. Off-site warehouse approvals with no period of validity are revoked, and their holders must apply for a new approval within six months of entry into force; approvals for secondary packaging facilities outside the factory site lapse one year after promulgation.[7:1] Pharmaceutical management facilities that already held a statement of CDOB compliance keep it, read as a CDOB certificate. Those at national and provincial level must hold a CDOB certificate within five years of promulgation, and those at district and city level within seven years.[7:2]

Pasal 98 revokes Peraturan Kepala BPOM Nomor HK.04.1.33.12.11.09937 Tahun 2011 on CPOB certification procedure and Peraturan Kepala BPOM Nomor 25 Tahun 2017 on CDOB certification procedure, together with Peraturan BPOM Nomor 20 Tahun 2025 on the CDOB standard to the extent that it governs the application of the standard by pharmaceutical management facilities as proved by a CDOB certificate. Under Pasal 99 the regulation took effect on promulgation.[8:1][2:1]

Relationship to other instruments

The regulation ties certification to business licensing. Manufacturers and distributors must hold a business identification number or business licence, from which government production facilities and pharmaceutical management facilities that are not public service agencies are exempt, and CPOB applications run through the online single submission system of the risk-based licensing regime that PP 28/2025 governs.[3:3][11:2][4:4] The certification fees charged under Pasal 9 and Pasal 71 are non-tax state revenue; the schedule of such revenue at BPOM in PP 15/2026 sets 15,000,000 rupiah per certificate per dosage form for a new CPOB certificate and 7,000,000 rupiah for the extension of a CPOB or CDOB certificate.[12:1][20:1][25] The certificates cover the manufacturing and wholesale stages of the supply chain. BPOM's supervision of how medicines are handled once they reach pharmacies, the pharmacy units of hospitals, community health centres and clinics, drug stores and self-service retailers is the subject of Peraturan BPOM 5/2026, issued in March 2026.[26]

CRPG's regulatory tracker published an account of the regulation on 20 November 2026.[27]

See also

Identifiers Know ID K294 · Work URI /akn/id/act/peraturan-bpom/2026/16 · RegVault PERATURAN_BPOM_16_2026

References


  1. [P] Peraturan BPOM No. 16 Tahun 2026 tentang Sertifikasi Cara Pembuatan Obat yang Baik dan Cara Distribusi Obat yang Baik, closing formula: Ditetapkan di Jakarta pada tanggal 3 September 2026, signed by Taruna Ikrar as Head of BPOM. The date of promulgation and the Berita Negara number are blank in the held text. regulation_id PERATURAN_BPOM_16_2026. ↩︎

  2. [P] Peraturan BPOM No. 16 Tahun 2026, JDIH BPK: enacted 3 September 2026, promulgated and in force 29 September 2026, Berita Negara 2026 No. 678; read with Pasal 99 (in force on promulgation). https://peraturan.bpk.go.id/Details/358324/peraturan-bpom-no-16-tahun-2026-sertifikasi-cara-pembuatan-obat-yang-baik-dan-ca ↩︎ ↩︎

  3. [P] Peraturan BPOM 16/2026, Pasal 2 ayat (1) to (8) and Pasal 3 ayat (1) to (5). regulation_id PERATURAN_BPOM_16_2026. ↩︎ ↩︎ ↩︎ ↩︎

  4. [P] Peraturan BPOM 16/2026, Pasal 62 ayat (1) to (5), Pasal 63 ayat (1) and (2) and Pasal 64 ayat (1) to (3). regulation_id PERATURAN_BPOM_16_2026. ↩︎ ↩︎ ↩︎ ↩︎ ↩︎

  5. [P] Peraturan BPOM 16/2026, Pasal 53 ayat (1) and Pasal 54 ayat (1). regulation_id PERATURAN_BPOM_16_2026. ↩︎ ↩︎ ↩︎

  6. [P] Peraturan BPOM 16/2026, Pasal 92 ayat (1). regulation_id PERATURAN_BPOM_16_2026. ↩︎ ↩︎

  7. [P] Peraturan BPOM 16/2026, Pasal 97 ayat (1) to (9). regulation_id PERATURAN_BPOM_16_2026. ↩︎ ↩︎ ↩︎

  8. [P] Peraturan BPOM 16/2026, Pasal 98 huruf a to c, citing the 2011 rule as Berita Negara 2012 No. 397, the 2017 rule as Berita Negara 2017 No. 1693 and Peraturan BPOM 20/2025 as Berita Negara 2025 No. 472. regulation_id PERATURAN_BPOM_16_2026. ↩︎ ↩︎

  9. [P] Peraturan BPOM 16/2026, preamble, Menimbang huruf a to d and Mengingat angka 1 to 5 (PP 28/2024, PP 28/2025, Perpres 80/2017, Peraturan BPOM 21/2020 as amended, Peraturan BPOM 19/2023 as amended). regulation_id PERATURAN_BPOM_16_2026. ↩︎ ↩︎

  10. [P] Peraturan BPOM 16/2026, Pasal 1 angka 3 to 6 and 8 to 14. regulation_id PERATURAN_BPOM_16_2026. ↩︎ ↩︎

  11. [P] Peraturan BPOM 16/2026, Pasal 4 ayat (1) and (2) and Pasal 6. regulation_id PERATURAN_BPOM_16_2026. ↩︎ ↩︎ ↩︎

  12. [P] Peraturan BPOM 16/2026, Pasal 7 ayat (1), Pasal 8 ayat (1) and (4), Pasal 9 ayat (1) to (3) and Pasal 10 ayat (1) to (9); Hari means working day (Pasal 1 angka 19). regulation_id PERATURAN_BPOM_16_2026. ↩︎ ↩︎

  13. [P] Peraturan BPOM 16/2026, Pasal 11 ayat (1), Pasal 12 and Pasal 13 ayat (1), (3) and (4). regulation_id PERATURAN_BPOM_16_2026. ↩︎

  14. [P] Peraturan BPOM 16/2026, Pasal 32 ayat (2). regulation_id PERATURAN_BPOM_16_2026. ↩︎

  15. [P] Peraturan BPOM 16/2026, Pasal 14 ayat (1) to (3). regulation_id PERATURAN_BPOM_16_2026. ↩︎

  16. [P] Peraturan BPOM 16/2026, Pasal 55, Pasal 56 ayat (2) and (3) and Pasal 57. regulation_id PERATURAN_BPOM_16_2026. ↩︎

  17. [P] Peraturan BPOM 16/2026, Pasal 61 ayat (1). regulation_id PERATURAN_BPOM_16_2026. ↩︎

  18. [P] Peraturan BPOM 16/2026, Pasal 65 ayat (3) and (4). regulation_id PERATURAN_BPOM_16_2026. ↩︎

  19. [P] Peraturan BPOM 16/2026, Pasal 66 ayat (1) and (4) and Pasal 68. regulation_id PERATURAN_BPOM_16_2026. ↩︎

  20. [P] Peraturan BPOM 16/2026, Pasal 70 ayat (1), Pasal 71, Pasal 72 ayat (1) to (5) and Pasal 74 ayat (1) and (2). regulation_id PERATURAN_BPOM_16_2026. ↩︎ ↩︎

  21. [P] Peraturan BPOM 16/2026, Pasal 85 ayat (2). regulation_id PERATURAN_BPOM_16_2026. ↩︎

  22. [P] Peraturan BPOM 16/2026, Pasal 93 ayat (1) to (3). regulation_id PERATURAN_BPOM_16_2026. ↩︎

  23. [P] Peraturan BPOM 16/2026, Pasal 94 ayat (1) to (5). regulation_id PERATURAN_BPOM_16_2026. ↩︎

  24. [P] Peraturan BPOM 16/2026, Pasal 95 ayat (1) to (3) and Pasal 96. regulation_id PERATURAN_BPOM_16_2026. ↩︎

  25. [P] Peraturan Pemerintah No. 15 Tahun 2026 tentang Jenis dan Tarif atas Jenis Penerimaan Negara Bukan Pajak yang Berlaku pada Badan Pengawas Obat dan Makanan, Lampiran, part III (Jasa Sertifikasi dan Penerbitan Izin Penerapan), items A.1, A.5 and C.4; signed and promulgated 27 March 2026, LN 2026 No. 35. regulation_id PP_15_2026. ↩︎

  26. [P] Peraturan BPOM No. 5 Tahun 2026 tentang Pengawasan Pengelolaan Obat dan Bahan Obat di Fasilitas Pelayanan Kefarmasian dan Fasilitas Lain, JDIH BPK: signed 13 March 2026. regulation_id PERATURAN_BPOM_5_2026. https://peraturan.bpk.go.id/Details/350939/peraturan-bpom-no-5-tahun-2026 ↩︎

  27. [E] "Certification of Good Manufacturing and Distribution Practice for Medicines: PERATURAN BPOM 16/2026", CRPG regulatory tracker, crpg.id, 20 November 2026. https://crpg.id/certification-of-good-manufacturing-and-distribution-practice-for-medicines-peraturan-bpom-16-2026/ The post carries a notice that it is AI-generated; it is cited for the record of the development, not for its legal content. ↩︎